| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-287 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-04001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-388
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0587
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36114
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-363
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0464 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-363
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36 |
| filingDate |
2016-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a3f0c460cbb4385daece741c7ff7635
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd792ca03251712c8b0bb9d99fbae925 |
| publicationDate |
2018-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2018116541-A1 |
| titleOfInvention |
System and Method for Monitoring and Treating Arrhythmia and Cardiac Function via the Intrinsic Cardiac Nervous System |
| abstract |
The present invention includes systems and methods for measuring, monitoring and treating arrhythmia and cardiac function via the intrinsic cardiac nervous system. The systems and methods compare neural signatures of the intrinsic cardiac nervous system that are associated with both healthy and diseased myocardial tissue to identify and target afferent intrinsic cardiac neurons for which signaling has been affected by diseased cardiac tissue. Accordingly, methods of modulating afferent neural signals from the diseased myocardium to the intrinsic cardiac nervous system, intrathoracic extracardiac ganglia, and higher centers of the cardiac neuraxis are used as a novel therapeutic approach to mitigating ischemic heart disease. |
| priorityDate |
2015-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |